Statistics for An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis
Total visits
| views | |
|---|---|
| An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis | 53 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| nihms-1061544.pdf | 105 |
| java.util.UUID:dfb416ed-bc6e-4b82-8db7-c84fdcedd831 | 84 |
| java.util.UUID:3ce0b91d-3f80-4ceb-8e40-1542651b5772 | 17 |
| java.util.UUID:985a6661-1a5f-4fe5-b9c4-9c61117fc3f7 | 7 |
Top country views
| views | |
|---|---|
| United States | 46 |
| China | 1 |
| South Korea | 1 |
| Philippines | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 41 |
| Cambridge | 2 |
| Ann Arbor | 1 |
| Chaoyang | 1 |